Urology Times Innovation Celebration: Expert Insights

In this interview, William P. Parker, MD, highlights the development of PSMA-PET imaging in prostate cancer, FDA-approved PSMA-PET agents, and the next steps with this disruptive technique.

In this interview, Howard Goldman, MD, discusses the development of sacral neuromodulation as a treatment for overactive bladder (OAB).

Eric S. Rovner, MD, discusses the use of bulking agents for stress urinary incontinence.

In this interview, Ziho Lee, MD, discusses the buccal mucosa graft for urethral and ureteral stricture disease.

Joshua A. Broghammer, MD, discusses the use of penile implants as an alternative to medication for the treatment of erectile dysfunction.